Singapore markets closed

Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
4.4700+0.0400 (+0.90%)
At close: 03:04PM CST

Shanxi Zhendong Pharmaceutical Co.,Ltd

Zhendong Science and Technology Park
Guangming South Road Shangdang District
Changzhi City 047100
China
86 35 5809 6012
https://www.zdjt.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees3,576

Key executives

NameTitlePayExercisedYear born
Mr. Lianmin YangPresident & Deputy GMN/AN/A1963
Mr. Changlu LiuFinancial DirectorN/AN/A1986
Zheyu WangSecretary of the Board of DirectorN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granules, as well as herbal medicines; and food and beverages for various health applications. The company engages in the pharmaceutical wholesale and logistics distribution business; tending, planting, processing, storage, and decoction of seedlings for medication applications; and offers home care and personal care products. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi City, China.

Corporate governance

Shanxi Zhendong Pharmaceutical Co.,Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.